Intrinsic Value of S&P & Nasdaq Contact Us

Catalent, Inc. CTLT NYSE

NYSE • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
44/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$74.25
+17%

Stock Statistics — CTLT

Catalent, Inc. (CTLT) has a market capitalization of $11.52B and trades at $63.48. The 52-week range is 42.11-63.5.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -11, Earnings Per Share (EPS) of $-5.76, annual revenue of $4.38B.

The stock has a beta of 1.16, operates in the Healthcare sector.

Trading Data
Current Price$63.48
52-Week Range42.11-63.5
Volume13.67M
Avg Volume (30D)2.27M
Market Cap$11.52B
Beta (1Y)1.16
Company
IPO Date2014-07-31
Employees17,000
CEOAlessandro Maselli
CountryUS
ExchangeNYSE
CurrencyUSD
ISINUS1488061029
CUSIP148806102
Income (Latest Year)
Revenue$4.38B
Gross Profit$953M
EBITDA$-284M
Operating Income$-749M
Net Income$-1.04B
EPS$-5.76
EPS Diluted$-5.76
Shares Outstanding$181M
Balance Sheet (Latest Year)
Total Assets$9.75B
Current Assets$2.6B
Cash & ST Investments$289M
Total Liabilities$6.15B
Total Debt$4.92B
Net Debt$4.63B
Total Equity$3.6B
Debt / Equity1.36
Valuation Ratios
P/E Ratio-11
P/S Ratio2.63
P/B Ratio3.2
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message